Madden Mary, Stewart Duncan, Cambridge Jim Mc
Department of Health Sciences, University of York, York, UK.
Centre for Primary Health and Social Care, School of Social Professions, London Metropolitan University Department, London, UK.
Addict Res Theory. 2023 Apr 28;31(6):459-467. doi: 10.1080/16066359.2023.2207017.
Alcohol is often overlooked in primary care even though it has wide-ranging impacts. The Structured Medication Review (SMR) in England is a new 'holistic' service designed to tackle problematic polypharmacy, delivered by clinical pharmacists in a general practice setting. Implementation has been protracted owing to the COVID-19 pandemic. This study explores early patient experiences of the SMR and views on the acceptability of integrating clinical attention to alcohol as another drug linked to their conditions and medicines, rather than as a standalone 'healthy living' or 'lifestyle' question.
Semi-structured interviews with a sample of 10 patients who drank alcohol twice or more each week, recruited to the study by five clinical pharmacists during routine SMR delivery.
SMRs received were remote, brief, and paid scant attention to alcohol. Interviewees were interested in the possibility of receiving integrated attention to alcohol within a SMR that was similar to the service specification. They saw alcohol inclusion as congruent with the aims of a holistic medicines review linked to their medical history. For some, considering alcohol as a drug impacting on their medications and the conditions for which they were prescribed, introduced a new frame for thinking about their own drinking.
Including alcohol in SMRs and changing the framing of alcohol away from a brief check with little meaningful scope for discussion, toward being fully integrated within the consultation, was welcomed as a concept by participants in this study. This was not their current medication review experience.
尽管酒精有广泛影响,但在初级医疗保健中它常常被忽视。英国的结构化药物审查(SMR)是一项新的“整体”服务,旨在解决复杂的多重用药问题,由临床药师在全科医疗环境中提供。由于新冠疫情,其实施过程一直很漫长。本研究探讨了患者对SMR的早期体验,以及对于将对酒精的临床关注作为与他们的病情和药物相关的另一种药物,而非作为一个独立的“健康生活”或“生活方式”问题的可接受性的看法。
对10名每周饮酒两次或更多次的患者进行半结构化访谈,这10名患者由5名临床药师在常规SMR服务期间招募入组。
所接受的SMR是远程的、简短的,且很少关注酒精问题。受访者对在类似于服务规范的SMR中接受对酒精的综合关注的可能性感兴趣。他们认为将酒精纳入与他们的病史相关的整体药物审查目标是一致的。对一些人来说,将酒精视为一种影响其药物和所服用药物治疗疾病的药物,为思考自己的饮酒行为引入了一个新的框架。
本研究的参与者欢迎将酒精纳入SMR,并将对酒精的框架设定从几乎没有有意义讨论范围的简短检查,转变为在会诊中完全整合,而这并非他们当前的药物审查体验。